Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Talbot

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Statistics in Medicine|March 13, 2025
Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time-To-Event OutcomesDenis Talbot, Awa Diop, Miceline Mésidor, et al.
The Lancet. Infectious Diseases|September 24, 2022
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control studySara Carazo, Danuta M Skowronski, Marc Brisson, et al.
BMC Medical Informatics and Decision Making|July 21, 2021
Exploring polypharmacy with artificial intelligence: data analysis protocolCaroline Sirois, Richard Khoury, Audrey Durand, et al.
International Journal of Environmental Research and Public Health|March 29, 2023
Work-Related Psychosocial Factors and Global Cognitive Function: Are Telomere Length and Low-Grade Inflammation Potential Mediators of This Association?Caroline S Duchaine, Chantal Brisson, Caroline Diorio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 30, 2021
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, CanadaSara Carazo, Denis Talbot, Nicole Boulianne, et al.
JAMA Network Open|October 14, 2022
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, CanadaSara Carazo, Danuta M Skowronski, Marc Brisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II studyRonald Natale, Fiona Blackhall, Dariusz Kowalski, et al.
JAMA Psychiatry|April 3, 2020
Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder: A Systematic Review and Meta-analysisCaroline S Duchaine, Karine Aubé, Mahée Gilbert-Ouimet, et al.
BMJ Open|April 26, 2024
Value-based comparison of ambulatory children with respiratory diseases in an emergency department and a walk-in clinic: a retrospective cohort study in Québec, CanadaTania Marx, Lynne Moore, Denis Talbot, et al.
Frontiers in Oncology|March 1, 2021
<i>nab</i>-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)Daniel Morgensztern, Manuel Cobo Dols, Santiago Ponce Aix, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Statistics in Medicine|March 13, 2025
Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time-To-Event OutcomesDenis Talbot, Awa Diop, Miceline Mésidor, et al.
The Lancet. Infectious Diseases|September 24, 2022
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control studySara Carazo, Danuta M Skowronski, Marc Brisson, et al.
BMC Medical Informatics and Decision Making|July 21, 2021
Exploring polypharmacy with artificial intelligence: data analysis protocolCaroline Sirois, Richard Khoury, Audrey Durand, et al.
International Journal of Environmental Research and Public Health|March 29, 2023
Work-Related Psychosocial Factors and Global Cognitive Function: Are Telomere Length and Low-Grade Inflammation Potential Mediators of This Association?Caroline S Duchaine, Chantal Brisson, Caroline Diorio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 30, 2021
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, CanadaSara Carazo, Denis Talbot, Nicole Boulianne, et al.
JAMA Network Open|October 14, 2022
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, CanadaSara Carazo, Danuta M Skowronski, Marc Brisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II studyRonald Natale, Fiona Blackhall, Dariusz Kowalski, et al.
JAMA Psychiatry|April 3, 2020
Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder: A Systematic Review and Meta-analysisCaroline S Duchaine, Karine Aubé, Mahée Gilbert-Ouimet, et al.
BMJ Open|April 26, 2024
Value-based comparison of ambulatory children with respiratory diseases in an emergency department and a walk-in clinic: a retrospective cohort study in Québec, CanadaTania Marx, Lynne Moore, Denis Talbot, et al.
Frontiers in Oncology|March 1, 2021
<i>nab</i>-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)Daniel Morgensztern, Manuel Cobo Dols, Santiago Ponce Aix, et al.
Pageof 13